Cytecare Cancer Hospitals has appointed Dr. Selwyn Colaco as the chief operating officer. He will lead the development and management of strategic clinical and business operations for the hospital network. The new hospital located in Bengaluru at Yelahanka near the international airport will be commissioned in a few months. No other details were available. The hospital is primarily equity funded and has raised about Rs.165 crore from global investors.

Dr. Selwyn is a physician manager and empanelled NABH assessor, with over two decades of clinical and management experience. He has worked in several hospitals including Manipal Hospital, Apollo Health, Narayana Health, BGS Global and most recently, Fortis Hospitals. He brings decades of valuable healthcare delivery, process consulting and people management expertise necessary to create a paradigm shift in cancer care.

Commenting on the appointment, Suresh Ramu, CEO and co-founder, Cytecare Hospitals said that the new hospital aims to revolutionise cancer treatment in India by delivering personalised cancer care across all aspects right from diagnosis to treatment and post-discharge. This requires implementation and adherence to global guidelines and the right governance of care.

“There is a dearth of research data, effective implementation and governance of standard evidence-based protocols for cancer therapy in India. Understanding this need, we will pioneer process-driven, organ-site focused, patient-centric cancer care. I am happy to be part of this transformational journey and our team will continue to monitor, develop, enhance and scale the overall operations of the hospital network,” said Dr. Selwyn Colaco, chief operating officer, Cytecare Hospitals.

The clinical excellence supervised by a multi-disciplinary Tumour Board. It is led by a team of over 100 employees manned with experience in healthcare and life sciences in Asia, Africa and India. Its will offer chemotherapy, advanced surgical and critical care capabilities including advanced operating rooms, ICUs, and radiotherapy along with nuclear medicine (PET-CT), radiology, diagnostics, laboratory and full-fledged blood bank backed by global standards and protocols in prevention and treatment of cancer. It will also partner with various technology and medical equipment companies. It is now working to provide solutions in Hospital Information Management, Electronic Health Records, Enterprise Resource Planning (ERP), and Building Management Systems (BMS) to create an efficient technology layer to support the hospital operations, according to Cytecare.